Clinical Trials Logo

Filter by:
NCT ID: NCT00221663 Terminated - Clinical trials for Heart Valve Diseases

Conventional Versus Mini-Sternotomy for Aortic Valve Surgery

Start date: January 2002
Phase: Phase 2/Phase 3
Study type: Interventional

Minimally-invasive operative techniques have been introduced in cardiac surgery. These techniques may have several advantages such as a decrease in post operative pain, lower morbidity and mortality, faster recovery, and a shorter hospital stay. However, these advantages have rarely been documented in the setting of a formal randomized controlled trial.

NCT ID: NCT00221637 Terminated - Neuralgia Clinical Trials

Efficacy of Valproate in Peripheral Neuropathic Pain

Start date: March 2002
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether valproate is effective and well tolerated in the treatment of neuropathic peripheral pain. The drug is administered by intravenous route followed by oral route during 4 weeks.

NCT ID: NCT00219908 Terminated - Clinical trials for Relapsing-Remitting Multiple Sclerosis

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis

Start date: July 1999
Phase: Phase 2
Study type: Interventional

The aim of the study is to determine whether a therapeutic strategy combining mitoxantrone and interferon beta1b can delay disease progression of at least one point on EDSS scale in patients with clinically very active relapsing-remitting multiple sclerosis.

NCT ID: NCT00219778 Terminated - Leiomyoma Clinical Trials

A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas

Start date: December 2004
Phase: Phase 2
Study type: Interventional

The first indication of hysterectomies in France are uterine leiomyomas. When they are symptomatic leiomyomas are particularly responsables of an increase of menstruations duration and volume. Echography is the reference exam for the diagnosis. It exists two treatments ways:-firstly progestatives and antifibrinolytics for the treatment of hemorragic symptoms, -secondly LH-RH analogs for the treatment of leiomyomas volume and hemorragic symptoms but just used for a small period because of the risk of osteoporosis. Different studies with different doses of mifepristone were released. The authors observe a decrease of leiomyomas volume. Based on this experience the present placebo controlled study has for objectives:-to confirm the efficacy of 10 mg oral mifepristone during 24 weeks in the volume decrease and in symptoms of leiomyomas, - to assess the safety of the treatment. The aim is to avoid or delay the hysterectomy of non menopausal patients. During the study patients will be evaluated with biological exams, clinical exams, echographies, medical interrogations and their diary cards.

NCT ID: NCT00219765 Terminated - Clinical trials for Chronic Myeloid Leukemia

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Start date: May 2001
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this phase I/II trial is to determine the dose of daunorubicine to be associated with cytarabine and Imatinib for induction therapy in patients with chronic myelogenous leukemia in myeloid acute phase.

NCT ID: NCT00219713 Terminated - Pain Clinical Trials

Evaluation of Pain Intensity During Bone Marrow Biopsy Performed With Inhalation of Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture.

Start date: March 2000
Phase: Phase 3
Study type: Interventional

Bone marrow biopsy is a painful medical procedure often performed with local anesthetic. Therefore a double-blind, randomized, controlled trial was carried out in 330 adult patients who where referred for bone marrow biopsy and aspiration. 164 were assigned to inhale an equimolar mixture of nitrous oxide and oxygen and 166 to inhale a placebo. Pain measurement used visual-analogue pain scales, which involve rating the intensity of pain on a horizontal ruler

NCT ID: NCT00213889 Terminated - Cleft Lip Clinical Trials

TWIST Human Gene and Cleft Lips and Palates

Start date: February 2003
Phase: N/A
Study type: Interventional

This study uses a sequence analysis for TWIST and other craniofacial development genes, among patients presenting with facial clefting.

NCT ID: NCT00213824 Terminated - Clinical trials for Amyotrophic Lateral Sclerosis

A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis

Start date: February 2004
Phase: N/A
Study type: Observational

This is a study of the expression of nogo and reticulon genes in the skeletal muscle of patients with amyotrophic lateral sclerosis (ALS).

NCT ID: NCT00213720 Terminated - Atrial Fibrillation Clinical Trials

Treatment of Subclinical Hyperthyroidism

Start date: August 2005
Phase:
Study type: Observational

Objective: To determine if the treatment of subclinical hyperthyroidism will reduce the rate of atrial fibrillation, the main complication of this condition.

NCT ID: NCT00213577 Terminated - Overactive Bladder Clinical Trials

NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder

Start date: December 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy and tolerance of 2 dosages (750 versus 500 units) of the Dysport type A botulinic toxin for patient suffering from neurogenic urinary incontinence by an overactive bladder and the failure of anticholinergic drugs.